Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE) için istatistikler

Toplam ziyaret

views
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE) 0

Aylık toplam ziyaret

views
Ekim 2024 0
Kasım 2024 0
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0